Prediction of lower-grade glioma molecular subtypes using deep learning

Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas

(2019) Hao Zhou et al.   JOURNAL OF NEURO-ONCOLOGY

Radiomics-based machine learning methods for isocitrate dehydrogenase genotype prediction of diffuse gliomas

(2019) Shuang Wu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

A radiomics nomogram may improve the prediction of IDH genotype for astrocytoma before surgery

(2019) Yan Tan et al.   EUROPEAN RADIOLOGY

Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype

(2019) S.H. Patel et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas

(2019) Yasukazu Fukuya et al.   JOURNAL OF NEURO-ONCOLOGY

Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system

(2019) Hiroaki Takei et al.   JOURNAL OF NEUROSURGERY

A surgical strategy for lower grade gliomas using intraoperative molecular diagnosis

(2018) Shunichi Koriyama et al.   Brain Tumor Pathology

Machine Learning-Based Radiomics for Molecular Subtyping of Gliomas

(2018) Chia-Feng Lu et al.   CLINICAL CANCER RESEARCH

Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI

(2018) Yu Fujii et al.   JOURNAL OF NEUROSURGERY

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study

(2018) Martinus P G Broen et al.   NEURO-ONCOLOGY

cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

(2018) Daniel J. Brat et al.   ACTA NEUROPATHOLOGICA

Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas

(2018) Hideyuki Arita et al.   Scientific Reports

Multimodal 3D DenseNet for IDH Genotype Prediction in Gliomas

(2018) Sen Liang et al.   Genes

Anaplastic Glioma: Treatment Approaches in the Era of Molecular Diagnostics

(2018) Michael W. Ruff et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Classification of the glioma grading using radiomics analysis

(2018) Hwan-ho Cho et al.   PeerJ

Predicting Deletion of Chromosomal Arms 1p/19q in Low-Grade Gliomas from MR Images Using Machine Intelligence

(2017) Zeynettin Akkus et al.   JOURNAL OF DIGITAL IMAGING

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

(2017) Martin J van den Bent et al.   LANCET

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis

(2017) Maarten M J Wijnenga et al.   NEURO-ONCOLOGY

MRI radiomics analysis of molecular alterations in low-grade gliomas

(2017) Ben Shofty et al.   International Journal of Computer Assisted Radiology and Surgery

Diffusion tensor image features predict IDH genotype in newly diagnosed WHO grade II/III gliomas

(2017) Paul Eichinger et al.   Scientific Reports

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Calcification on CT is a simple and valuable preoperative indicator of 1p/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas

(2016) Taiichi Saito et al.   Brain Tumor Pathology

Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion

(2016) Tomohiro Kawaguchi et al.   JOURNAL OF NEURO-ONCOLOGY

Mutational landscape and clonal architecture in grade II and III gliomas

(2015) Hiromichi Suzuki et al.   NATURE GENETICS

Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection

(2015) Masayuki Nitta et al.   Neurosurgical Focus

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

A new philosophy in surgery for diffuse low-grade glioma (DLGG): Oncological and functional outcomes

(2013) H. Duffau   NEUROCHIRURGIE

Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

(2012) Gregory Cairncross et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

(2012) Martin J. van den Bent et al.   JOURNAL OF CLINICAL ONCOLOGY

The Value of Glioma Extent of Resection in the Modern Neurosurgical Era

(2012) Douglas A. Hardesty et al.   Frontiers in Neurology

Analysis of11C-methionine Uptake in Low-Grade Gliomas and Correlation with Proliferative Activity

(2008) T. Kato et al.   AMERICAN JOURNAL OF NEURORADIOLOGY